GI Dynamics' EndoBarrier weight loss and diabetes device, wins a reimbursement nod from German authorities.
GI Dynamics (ASX:GID) said it won a reimbursement nod in Germany for its flagship EndoBarrier weight loss and diabetes device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ipYNdL
Cap comentari:
Publica un comentari a l'entrada